Jobs
About this role
The Senior Market Access Manager is responsible for shaping and executing Biogen’s value and access strategy in Gulf. This role ensures optimal and sustainable patient access to Biogen’s portfolio through proactive engagement with key stakeholders, development of robust access strategies, and strong internal cross functional alignment.
The position encompasses early access programs (EAPs/Charged Managed Access Programs), HTA engagement, pricing and reimbursement, formulary access, and value communication.
What You'll Do
Market Access Strategy & Execution:
-
Develop and implement market access strategies to secure and maintain optimal patient access across Biogen’s portfolio in Gulf.
-
Monitor evolving healthcare policies, payer priorities, and competitor dynamics to anticipate risks and opportunities.
-
Lead pricing and reimbursement submissions in collaboration with the Pricing & Tender Lead, Regulatory Affairs, Medical, and Commercial teams.
-
Design and execute pricing tactics, tender approaches, and contracting models tailored to specific customer segments.
-
Track and report market access performance indicators, providing insights and recommendations to senior management.
Stakeholder Engagement
-
Build deep customer understanding and drive engagement with key stakeholders across governmental and private channels.
-
Engage proactively with payers, health authorities, HTA bodies, and institutional decision-makers to communicate product value and support access objectives.
-
Map, develop, and execute strategic stakeholder engagement plans aligned with budgets and business priorities.
Value & Evidence Communication:
-
Lead the development and localization of healtheconomic models, value dossiers, and communication tools to support payer negotiations and product positioning.
-
Ensure consistent and compelling articulation of Biogen’s value propositions across all access interactions.
Cross-functional Collaboration
-
Drive strong internal collaboration across regulatory, medical, commercial, and finance teams to ensure aligned execution of access initiatives.
-
Provide market insights to inform brand planning, forecasting, and strategic portfolio decisions.
Who You Are
You bring strong expertise in the Gulf market access landscape and maintain solid relationships with key governmental and private sector stakeholders. You combine strategic thinking with strong stakeholder engagement skills and are able to clearly articulate product value to payers and decision makers. You are collaborative, proactive, and comfortable working cross-functionally to drive access strategies in a complex and evolving healthcare environment.
Required Skills
-
Minimum 7 years’ experience in the Gulf pharmaceutical industry, with at least 4 years in Market Access or Key Account Management.
-
Strong existing network of key stakeholders across governmental and private institutions in GCC.
-
Deep knowledge of the Gulf healthcare policy, reimbursement systems, HTA processes, and access pathways.
-
Minimum 50% of time spent in the field engaging external stakeholders.
Job Level: Management
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

End User Key Accounts Manager
Schneider Electric · Bonifacio Global City, Philippines

Assistant Manager(09438) - 8711 FM 1409
Domino's · Baytown

Assistant Manager(04596) - 430 Market St
Domino's · Elmwood Park

3P Manager (Italian speaker), Amazon Pickup and Returns Points (PARP)
Amazon · Madrid, M, ESP

Engineering Controls (Leader - Senior Leader - Manager)
Halliburton ·
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Junior/L3
Mid/L4
Senior/L5
Director
Junior/L3 · Biomedical Engineer
0 reports
$150,960
total / year
Base
-
Stock
-
Bonus
-
$128,316
$173,604
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
6w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago